A low percentage of autologous serum can replace bovine serum to engineer human nasal cartilage
For the generation of cell-based therapeutic products, it would be preferable to avoid the use of animal-derived components. Our study thus aimed at investigating the possibility to replace foetal bovine serum (FBS) with autologous serum (AS) for the engineering of cartilage grafts using expanded hu...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AO Research Institute Davos
2008-02-01
|
| Series: | European Cells & Materials |
| Subjects: | |
| Online Access: | http://www.ecmjournal.org/journal/papers/vol015/pdf/v015a01.pdf |